Alison Murphy
11Patents
5h-index
20Co-inventors
62Inventor score
Filing activity: Mar 26, 2004 → Jul 26, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7638541B2 | 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine | Chemistry; Metallurgy | 33 | Active |
| US7223766B2 | Bi-cyclic pyrimidine inhibitors of TGFβ | Chemistry; Metallurgy | 25 | Expired |
| US8183381B2 | N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | Chemistry; Metallurgy | 11 | Active |
| US8227495B2 | 2,4-disubsituted thiazoles and pharmaceutical compositions thereof | Chemistry; Metallurgy | 10 | Active |
| US8288384B2 | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | Chemistry; Metallurgy | 7 | Active |
| US7232824B2 | Quinazoline derivatives as medicaments | Chemistry; Metallurgy | 4 | Expired |
| US9737537B2 | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | Chemistry; Metallurgy | 1 | Active |
| US8846675B2 | N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | Chemistry; Metallurgy | 0 | Active |
| US8921350B2 | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | Chemistry; Metallurgy | 0 | Active |
| US8975258B2 | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | Chemistry; Metallurgy | 0 | Active |
| US9925189B2 | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.